Conjunctivitis: all 361 studies
Page 3 of 4. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.
- Ocular Manifestations in Rheumatic DiseasesCompletedNCT03753893
- Safety and Tolerability of PRO-143 Ophthalmic Solution in Healthy Volunteers.WithdrawnNCT03698045Phase 1
- DRy Eye Outcome and Prescription StudyStatus unknownNCT03652415
- Feasibility Study and Preliminary Application Study on Iris OCTAStatus unknownNCT03631108
- Molekule for Allergic Rhinitis/AsthmaTerminatedNCT03627689Not applicable
- Prevalence of Conjunctivitis and Indentification of Risk Factors With and Without Prophylactic Antibiotic Treatment in NeonatesCompletedNCT03528915
- A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic ConjunctivitisCompletedNCT03379311Phase 1
- Evaluation of Subcutaneous Immunotherapy Towards Pollen in ChildrenCompletedNCT03375775Not applicable
- Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic ConjunctivitisCompletedNCT03368339Phase 2
- Efficacy and Safety of Lertal® as an add-on to Standard Therapy for Allergic Rhinoconjunctivitis in PediatricsCompletedNCT03365648Not applicable
- Epidemiology of Conjunctivitis in the Emergency DepartmentCompletedNCT03356197
- Local Pharmacokinetics of Azithromycin Eye Drops in Healthy VolunteersStatus unknownNCT03235141Phase 1
- Clinical Evaluation of Hylo-Dual Versus Patanol in Children With Seasonal Allergic ConjunctivitisStatus unknownNCT03186755Phase 4
- Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal ReseachersCompletedNCT03101618
- ADenoVirus Initiative Study in Epidemiology in ItalyCompletedNCT03055065
- Study Evaluating Safety of Ragweed Mix Given by Intralymphatic Node InjectionsTerminatedNCT03038971Phase 1
- Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)WithdrawnNCT03009799Phase 2
- Clinical Trial With Subcutaneous Immunotherapy in Depot Presentation in Patients With Allergic Rhinoconjunctivitis Sensitized to House Dust MitesCompletedNCT02881879Phase 1
- Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical PracticeCompletedNCT02844842
- Efficacy and Safety of Grass-SPIRE Registration StudyWithdrawnNCT02795273Phase 2/3
- Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Mite AllergyStatus unknownNCT02661854Phase 2
- Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen AllergyCompletedNCT02654223Phase 2
- Safety and Efficacy of Lastacaft® for the Prevention of Itching Associated With Allergic Conjunctivitis in KoreaCompletedNCT02555761
- Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte ExtractsCompletedNCT02506998Phase 2
- Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy PatientsCompletedNCT02503956Not applicable
- A Multi-Center Environmental Study for the Treatment of Moderate to Severe Ocular Allergic ConjunctivitisCompletedNCT02492321Phase 3
- Study for Evaluating Life Quality in Patients With RhinoconjunctivitisCompletedNCT02488447
- A Multicenter, Open Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Parietaria JudaicaCompletedNCT02477917Phase 1
- Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic AsthmaCompletedNCT02340130Phase 2
- Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without ConjunctivitisCompletedNCT02295969
- Compare Dose Regimens of AllerT, in Adults With Allergic Rhino-Conjunctivitis to Birch Pollen Studied in EECCompletedNCT02271009Phase 2
- ADenoVirus Initiative Study in Epidemiology in SpainCompletedNCT02254330
- SUBLIVAC FIX Birch Phase III Short-term EfficacyCompletedNCT02231307Phase 3
- Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic DermatitisCompletedNCT02148744Phase 1
- ADenoVirus Initiative Study in Epidemiology in UKCompletedNCT02112773
- A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)CompletedNCT02082899Phase 2
- ADenoVirus Initiative Study in Epidemiology in GermanyCompletedNCT02054273
- ADenoVirus Initiative Study in Epidemiology in FranceCompletedNCT02054234
- Therapeutic Efficacy of APD-209 Eye Drops in Treatment of Epidemic Keratoconjunctivitis (EKC)CompletedNCT01977443Phase 2
- ToleroMune House Dust Mite (HDM) Tolerability StudyCompletedNCT01949441Phase 2
- House Dust Mite Observational StudyCompletedNCT01949428
- An Optional Investigation of Biomarkers of EfficacyCompletedNCT01949415
- Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® BirchCompletedNCT01902992Phase 3
- The Effect of Pollen Season on Subcutaneous Allergen Immunotherapy ReactionsStatus unknownNCT01878929Phase 1/2
- Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial ConjunctivitisCompletedNCT01877694Phase 2
- Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic ConjunctivitisTerminatedNCT01860664Phase 2
- Ocular Allergy Treatment Practical Impact TrialStatus unknownNCT01808768Phase 4
- Artificial Tears Versus Preservative Free Ketorolac Trometamol 0.45% for Acute Viral ConjunctivitisCompletedNCT01799863Phase 2/3
- A Trial Evaluating Tolerability of Grazax Treatment in Combination With AntihistamineCompletedNCT01740284Phase 3
- Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic RhinoconjunctivitisCompletedNCT01731249Phase 3
- Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and InfectionWithdrawnNCT01721694Phase 3
- Depigoid Birch 5000 Longterm Study in Adults and AdolescentsCompletedNCT01694836Phase 3
- The Significance of Ambrosia in Allergic Rhinitis and Asthma in IsraelCompletedNCT01686048
- SUBLIVAC FIX Phleum Pratense DT/DRFCompletedNCT01682070Phase 2
- Clinical Efficacy of PRO-118 Compared With Olopatadine Hydrochloride Ophthalmic Solution in Allergic ConjunctivitisWithdrawnNCT01657240Phase 3
- Evaluation of the Onset and Duration of Action of RX-10045 in Allergic ConjunctivitisCompletedNCT01639846Phase 2
- SUBLIVAC FIX Birch Dose Tolerability/Dose Range FindingCompletedNCT01639768Phase 2
- Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-AsthmaCompletedNCT01634958Phase 2
- Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by AdenovirusStatus unknownNCT01600365Phase 3
- Safety Study of Depigoid Vaccine Dermatophagoides Pteronyssinus or 50% Dermatophagoides Pteronyssinus / 50% Dermatophagoides Farinae (500 DPP/ml), to Treat Allergic Rhinitis or Rhinoconjunctivitis With or Without AsthmaTerminatedNCT01591343Phase 2
- Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) ExtractCompletedNCT01564017Phase 2
- An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic ConjunctivitisCompletedNCT01561521Phase 3
- Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic ConjunctivitisWithdrawnNCT01541904Phase 2
- A Placebo Controlled Comparison of Topical Zirgan Versus Genteal Gel for the Treatment of Adenovirus ConjunctivitisCompletedNCT01533480Phase 4
- Efficacy and Safety of NVC-422 in the Treatment of Adenoviral ConjunctivitisCompletedNCT01532336Phase 2
- Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal RhinoconjunctivitisCompletedNCT01490411Phase 2
- Quality of Life and Health Economic Measurements in Allergic Patients Treated With ImmunotherapyCompletedNCT01486498
- A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral ConjunctivitisCompletedNCT01481519Phase 3
- The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to PlaceboCompletedNCT01471184Not applicable
- FST-100 in the Treatment of Acute Adenoviral ConjunctivitisCompletedNCT01470664Phase 2
- FST-100 in the Treatment of Acute Viral ConjunctivitisCompletedNCT01461954Phase 2
- PURETHAL® Mites Dose Range Finding Study in Patients With Persistent Allergic Rhinitis/RhinoconjunctivitisCompletedNCT01438463Phase 2
- A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%CompletedNCT01437982Phase 4
- Tolerability of Grazax in Patients With Hayfever in Real Life SettingsCompletedNCT01433510Phase 4
- Comparison of Different Up-dosing Schedules With Osiris Phleum PratenseCompletedNCT01425788Phase 2
- Comparison of Tolerability Between Two Allergy DropsStatus unknownNCT01390961Phase 4
- 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled AsthmaCompletedNCT01353755Phase 3
- Ganciclovir 0,15% Ophthalmic Gel in the Treatment of Adenovirus KeratoconjuntivitisCompletedNCT01349452Not applicable
- Safety and Efficacy of Ectoin Allergy Nasal Spray and Ectoin Allergy Eye Drops in the Treatment of Seasonal Allergic Rhinitis (SAR) in Children and AdolescentsCompletedNCT01342601Not applicable
- A Patient Reported Ocular Comfort Assessment Comparing Bepreve to LastacaftCompletedNCT01339507
- Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact LensesStatus unknownNCT01337557Phase 4
- Safety and Comfort of AL-4943A Ophthalmic SolutionCompletedNCT01326858Phase 1
- Patient Perception Study for AL-4943ACompletedNCT01294969Phase 4
- A Study to Evaluate the Safety and Efficacy of the QLT Proprietary Olopatadine-PPDS in Subjects With Seasonal Allergic Conjunctivitis to Ragweed in an Environmental Exposure Chamber Model.TerminatedNCT01287338Phase 2
- A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)CompletedNCT01275105Phase 2
- A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic ConjunctivitisCompletedNCT01272089Phase 4
- Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic ConjunctivitisCompletedNCT01258309Phase 3
- Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial ConjunctivitisWithdrawnNCT01238783Phase 2
- Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial ConjunctivitisStatus unknownNCT01227915Phase 3
- Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial ConjunctivitisStatus unknownNCT01227863Phase 3
- A Four Week, Open-Label Study of Azithromycin Ophthalmic Solution, 1% (P08641)TerminatedNCT01220258Phase 2
- Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis PatientsCompletedNCT01203540Phase 4
- Treatment of Epidemic Keratoconjunctivitis With 2% Povidone-iodineCompletedNCT01179412Phase 4
- Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-AsthmaCompletedNCT01144429Phase 2
- Study Evaluating the Efficacy of Administration of Cyclosporine (Low Dose and High Dose) and Prednisolone Acetate Compared to Its Components and Vehicle in Patients With Allergic ConjunctivitisCompletedNCT01120132Phase 2
- Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen RhinoconjunctivitisCompletedNCT01111279Phase 1
- Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Pediatric PatientsCompletedNCT01109485Phase 4
- Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)CompletedNCT01081574Phase 1/2
- An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic ConjunctivitisCompletedNCT01037179Phase 3
- Immunomodulation of E.Coli Nissle 1917 in Patients With Grass Pollen RhinoconjunctivitisCompletedNCT01013259Phase 2